Research We Fund
Upstage Lung Cancer is proud to have funded over $1 million in lung cancer research.
2016-2018: Early Detection
This grant was funded in part by Lungevity
Lida Hariri, MD, PhD
Massachusetts General Hospital/Harvard University, Boston, MA
A tissue biopsy is often required to make a definitive diagnosis of lung cancer. However, because of small size and inadequate biopsy yield, early-stage lung cancer is often difficult to diagnose. Dr. Hariri is using a novel imaging technique called optical coherence tomography (OCT) to develop tools to guide tissue biopsy sampling to improve tissue yield. These tools will also provide additional diagnostic information.